43 results
8-K
EX-10.1
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
,
(viii) to the Company from an employee of the Company upon death, disability or termination of employment, in each case, of such employee, or
(ix
8-K
8g8a 1s6rkibtkij7v
3 Oct 22
Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer
8:30am
8-K
qu98l93majtl t596ik0
1 Mar 22
Crinetics Pharmaceuticals Expands Executive Team with Appointment of James Hassard as Chief Commercial Officer
8:00am
8-K
EX-10.1
y75r9 7o4
23 Dec 21
Departure of Directors or Certain Officers
4:30pm
8-K
cf49lud gc
2 Sep 21
Crinetics Pharmaceuticals Expands Executive Team with Addition of Jeff Knight as Chief Operating Officer
5:00pm
DEF 14A
9p0e5dt0uhb
29 Apr 19
Definitive proxy
12:00am
424B4
qsjh8 n0o
18 Jul 18
Prospectus supplement with pricing info
5:27pm